Abstract

Background: Antibiotic-resistant type III/ST-17 Streptococcus agalactiae (group B Streptococcus, GBS) strain is predominant in neonatal invasive GBS diseases. We aimed to investigate the antibiotic resistance profiles and genetic characteristics of type III/ST-17 GBS strains. Methods: A total of 681 non-duplicate GBS isolates were typed (MLST, capsular types) and their antibiotic resistances were performed. Several molecular methods (WGS, PCR, sequencing and sequence analysis) were used to determine the genetic context of antibiotic resistant genes and pili genes. Results: The antibiotic resistant rates were significantly higher in type Ib (90.1%) and type III (71.1%) GBS isolates. WGS revealed that the loss of PI-1 genes and absence of ISSag5 was found in antibiotic-resistant III/ST-17 GBS isolates, which is replaced by a ~75-kb integrative and conjugative element, ICESag37, comprising multiple antibiotic resistance and virulence genes. Among 190 serotype III GBS isolates, the most common pilus island was PI-2b (58.4%) alone, which was found in 81.3% of the III/ST-17 GBS isolates. Loss of PI-1 and ISSag5 was significantly associated with antibiotic resistance (95.5% vs. 27.8%, p < 0.001). The presence of ICESag37 was found in 83.6% of all III/ST-17 GBS isolates and 99.1% (105/106) of the antibiotic-resistant III/ST-17 GBS isolates. Conclusions: Loss of PI-1 and ISSag5, which is replaced by ICESag37 carrying multiple antibiotic resistance genes, accounts for the high antibiotic resistance rate in III/ST-17 GBS isolates. The emerging clonal expansion of this hypervirulent strain with antibiotic resistance after acquisition of ICESag37 highlights the urgent need for continuous surveillance of GBS infections.

Highlights

  • Licensee MDPI, Basel, Switzerland.The opportunistic pathogen group B Streptococcus (GBS, known as Streptococcus agalactiae) is a commensal bacterium of the human genitourinary and digestive tracts and colonizes in 20–30% of pregnant women [1,2]

  • Most clinical isolates and human carriage strains can be clustered into several major clonal complexes (CCs) by multilocus sequence typing (MLST), with type III/CC17 being the most virulent strain that causes the majority of neonatal meningitis and late-onset diseases [3,4,5,6,7,8]

  • Recent genomebased studies found that many CC17/III Group B (GBS) strains displayed a high degree of genetic homology and spread of the specific clone has been reported [13,14,15]

Read more

Summary

Introduction

Licensee MDPI, Basel, Switzerland.The opportunistic pathogen group B Streptococcus (GBS, known as Streptococcus agalactiae) is a commensal bacterium of the human genitourinary and digestive tracts and colonizes in 20–30% of pregnant women [1,2]. Most clinical isolates and human carriage strains can be clustered into several major clonal complexes (CCs) by multilocus sequence typing (MLST), with type III/CC17 being the most virulent strain that causes the majority of neonatal meningitis and late-onset diseases [3,4,5,6,7,8]. Antibiotic-resistant type III/ST-17 Streptococcus agalactiae (group B Streptococcus, GBS) strain is predominant in neonatal invasive GBS diseases. We aimed to investigate the antibiotic resistance profiles and genetic characteristics of type III/ST-17 GBS strains. Methods: A total of 681 non-duplicate GBS isolates were typed (MLST, capsular types) and their antibiotic resistances were performed. Results: The antibiotic resistant rates were significantly higher in type Ib (90.1%) and type III (71.1%) GBS isolates.

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call